email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Bull Trader USA

Warren Buffett keeps selling billions worth of stock in this frothy market — here are 3 new places where he’s finding value

Motley Fool

Down 30% in 6 Months: Is Tilray Still a Buy?

The Canadian cannabis company Tilray (NASDAQ: TLRY) hasn’t been the best performer over the last six months, with its shares falling by more than 31% while the larger market rose by 14%. Is Tilray on track to be a strong performer in 2022, or is its tenuous positioning relative to the rapidly opening U.S. cannabis market going to be a problem? Right now, Tilray holds the largest share of the recreational and medicinal cannabis markets in Canada.

Post a Comment